cobra:bio

5 Year Financial Summary

Year Ended 30 September	2008	2007	2006	2005	2004
	IFRS	IFRS	IFRS	UK GAAP	UK GAAP
	£000's	£000's	£000's	£000's	£000's
Revenue	7,009	9,194	10,145	7,721	3,516
Gross profit	2,323	3,865	5,337	4,323	1,565
GP%	33%	42%	53%	56%	45%
Operating expenses	(5,389)	(5,700)	(5,335)	(4,675)	(3,949)

Operating (loss)/profit	(3,066)	(1,835)	2	(352)	(2,384)
Net finance (costs)/income	(316)	(50)	69	(43)	113

(Loss)/profit before tax	(3,382)	(1,885)	71	(395)	(2,271)
Taxation	107	110	55	54	(127)

(Loss)/profit after tax	(3,275)	(1,775)	126	(341)	(2,398)

(Loss)/earnings per share	(11.0p)	(9.1p)	0.6p	(1.7p)	(12.3p)

Cash at bank and in hand	291	1,338	3,215	3,036	3,159

Net assets	4,038	6,269	8,012	7,812	8,151

Market cap at B/S date	1,545	5,730	10,089	8,973	4,583

Average number of employees	123	136	118	94	88

COBRA is an Acronym for ‘Clinical Oncology Birmingham Research Associates’

News Alert

View privacy policy